In vitro, YKL-40 up-regulates VEGF in the U87 human glioblastoma cell line, and long-term inhibition of VEGF induces expression of YKL-40 (potentially as a compensatory response, i.e. ‘angiogenic rebound’) [9, 11–17]. This evidence concerns the gene VEGFA and glioblastoma.